Spots Global Cancer Trial Database for FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
Official Title: A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma
Study ID: NCT02448381
Conditions
Study Description
Brief Summary: To evaluate the use of SGX301, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Alabama Birmingham, Birmingham, Alabama, United States
University of Arizona, Phoenix, Arizona, United States
Mayo Clinic, Scottsdale, Arizona, United States
University of Arkansas, Little Rock, Arkansas, United States
Stanford University, Palo Alto, California, United States
Therapeutics Clinical Research, San Diego, California, United States
Olympian Clinical Research, Clearwater, Florida, United States
Leon Medical Research, Miami, Florida, United States
Medical Professional Clinical Research, Miami, Florida, United States
University of South Florida, Tampa, Florida, United States
Northwestern University, Chicago, Illinois, United States
Rush University, Chicago, Illinois, United States
Dawes Fretzin Dermatology Group, Indianapolis, Indiana, United States
Tulane University, New Orleans, Louisiana, United States
University of Maryland, Baltimore, Maryland, United States
University of Minnesota, Minneapolis, Minnesota, United States
Washington University, Saint Louis, Missouri, United States
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Rochester Skin Lymphoma Medical Group, Fairport, New York, United States
Columbia University Medical Center, New York, New York, United States
Stony Brook Medicine, Stony Brook, New York, United States
PMG Research of Wilmington, Wilmington, North Carolina, United States
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Jefferson Dermatology, Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Medical University of South Carolina, Charleston, South Carolina, United States
Vanderbilt University, Nashville, Tennessee, United States
MD Anderson, Houston, Texas, United States
Austin Institute for Clinical Research, Pflugerville, Texas, United States
INOVA Schar Cancer Institute, Fairfax, Virginia, United States
Virginia Clinical Research, Norfolk, Virginia, United States
Seattle Care Cancer Center, Seattle, Washington, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
